The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA 3) study: Rationale and study design

Europace

Volumn 1, Issue 1, 1999, Pages 40-42

  Gillis, A M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA ENVIRONMENT AND PARKS   (Canada)

Author keywords

Atrial pacing; Dual chamber pacing; Paroxysmal atrial fibrillation; Rate responsive pacing; Ventricular pacing

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; COMBINED MODALITY THERAPY; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 0032601115     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1998.0005     Document Type: Article

References (20)

1. Kay GN, Babien RS, Epstein AE, Plumb VJ. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol 1988; 62: 741-4.
2. Brignole L, Gianfranchi L, Menozzi C et al. Assessment of atrio-ventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997; 96: 2617-24.
3. Darpö B, Walfridsson H, Aunes M et al. Incidence of sudden death after radiofrequency ablation of the atrio-ventricular junction for atrial fibrillation. Am J Cardiol 1997; 80: 1174-7.
4. Peters R, Wever E, Hauer R, Wittkampf F, Robles de Medina E. Bradycardia-dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction with radiofrequency energy. J Am Coll Cardiol 1993; 21: 102-9.
5. Gribbin GM, Bourke JP, McComb JM. Dual versus single chamber pacemakers in patients with paroxysmal atrial fibrillation treated with AV node ablation (Abstr). PACE 1997; 20: 1592.
6. Rosenqvist M, Brandt J, Schüller HI. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22.
7. Sasaki Y, Shimotori M, Akahane K et al. Long-term follow-up of patients with sick sinus syndrome: A comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. PACE 1988; 11: 1575-83.
8. Stangl K, Seitz K, Wirtzfeld AHE, Blömer H. Differences between atrial single chamber (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990; 13: 2080-5.
9. Santini M, Alexidou G, Ansalone G, Cecciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects, and modes of permanent cardiac pacing. Am J Cardiol 1990; 65: 729-35.
10. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992; 19: 1542-9.
11. Sgarbossa EB, Pinski SL, Maloney JD et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88: 1045-53.
12. Andersen HR, Nielsen JC, Thomsen PEB et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210-6.
13. Coumel P, Friocourt P, Mugica J, Attuel P, LeClercq J-F. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases. PACE 1983; 6: 552-60.
14. Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. PACE 1988; 11: 1647-54.
15. Mehra R, Hill MRS. Prevention of atrial fibrillation/flutter by pacing techniques. In: Saksena S, Lüderitz B, eds. Interventional Electrophysiology: A Textbook, 2nd edn. Armonk, NY: Futura Publishing Company Inc.; 1996: 521-40.
16. Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Matthew PP, Mehra R. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996; 28: 687-94.
17. Murgatroyd F, Slade A, Nitzsche R, Camm AJ, Ritter P for the Chorous Multicentre Study Group. A new pacing algorithm for the suppression of atrial fibrillation (Abstr). PACE 1994; 17: 863.
18. Pritchett ELC, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 1991; 114: 539-44.
19. Anderson JL, Gilbert EM, Alpert BL et al Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind crossover study of flecainide and placebo with transtelephonic monitoring. Circulation 1989; 80: 1557-70.
20. Gillis AM, Connolly SJ, Yee R et al. Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation - Phase I. PACE 1998; 21: 872.